VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 7873 · 116th Congress

Epi for Dilly Act of 2020

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

1 cosponsor · 1 D

0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill requires the Department of Health and Human Services, when awarding certain grants for preventive health service programs, to give preference to states that allow trained individuals to administer epinephrine and that provide civil liability protections to those who do so.

What it does: CRS summary · Introduced in House · Jul 30, 2020

Epi for Dilly Act of 2020

This bill requires the Department of Health and Human Services, when awarding certain grants for preventive health service programs, to give preference to states that allow trained individuals to administer epinephrine and that provide civil liability protections to those who do so.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Epi for Dilly Act of 2020

Latest action (Jul 30, 2020): Referred to the House Committee on Energy and Commerce.

Policy area: Health · Origin: House · Introduced: Jul 30, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.